News
After Novo Nordisk stated that Hims & Hers Health would no longer be able to directly obtain its weight loss medication, Hims & Hers Health's stock price fell by 29.5%
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments